Inhibition of Human Telomerase by a G-Quadruplex-Interactive Compound
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
ADVERTISEMENT RETURN TO ISSUEPREVLetterNEXTInhibition of Human Telomerase by a G-Quadruplex-Interactive CompoundDaekyu Sun, Brian Thompson, Brian E. Cathers, Miguel Salazar, Sean M. Kerwin, John O. Trent, Terence C. Jenkins, Stephen Neidle, and Laurence H. HurleyView Author Information Institute for Drug Development, 14960 Omicron Drive, San Antonio, Texas 78245-3217, College of Pharmacy, The University of Texas at Austin, Austin, Texas 78712-1074, and CRC Biomolecular Structure Unit, The Institute of Cancer Research, Cotswold Road, Sutton, Surrey SM2 5NG, United Kingdom Cite this: J. Med. Chem. 1997, 40, 14, 2113–2116Publication Date (Web):July 4, 1997Publication History Received25 March 1997Published online4 July 1997Published inissue 1 July 1997https://pubs.acs.org/doi/10.1021/jm970199zhttps://doi.org/10.1021/jm970199zrapid-communicationACS PublicationsCopyright © 1997 American Chemical SocietyRequest reuse permissionsArticle Views5835Altmetric-Citations687LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-AlertscloseSupporting Info (1)»Supporting Information Supporting Information SUBJECTS:Chemical structure,G-Quadruplex,Genetics,Inhibition,Peptides and proteins Get e-Alerts
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several strategies to inhibit telomerase activity have been reported.These include peptide nucleic acids and 2¢-O-MeRNA oligonucleotides directed towards the telomerase RNA template (Herbert et al., 1999), compounds that target telomeric DNA such as cationic porphyrins or anthraquinones (Sun et al., 1997) and nucleosidic reverse transcriptase inhibitors (Strahl and Blackburn, 1996).”
From A highly selective telomerase inhibitor limiting human cancer cell proliferation (2001) · cites this paper as Sun et al., 1997
Citations
Cites
Telomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
Structure and function of telomeres
Blackburn, E. H. (1991) · Nature · doi:10.1038/350569a0 · Cited by 3,596
The RNA Component of Human Telomerase
Feng, J., Funk, W. D., Wang, S.-S., Weinrich, S. L., Avilion, A. A., Chiu, C.-P., Adams, R. R., Chang, E., Allsopp, R. C., Yu, J., et al. (1995) · Science · doi:10.1126/science.7544491 · Cited by 2,227
Counter, C. M., Avilion, A. A., LeFeuvre, C. E., Stewart, N. G., Greider, C. W., Harley, C. B., & Bacchetti, S. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05245.x · Cited by 2,096
Inhibition of telomerase by G-quartet DMA structures
Zahler, A. M., Williamson, J. R., Cech, T. R., & Prescott, D. M. (1991) · Nature · doi:10.1038/350718a0 · Cited by 1,134
Divne, C., Ståhlberg, J., Reinikainen, T., Ruohonen, L., Pettersson, G., Knowles, J. K. C., Teeri, T. T., & Jones, T. A. (1994) · Science · doi:10.1126/science.8036495 · Cited by 626
Correlating telomerase activity levels with human neuroblastoma outcomes
Hiyama, E., Hiyama, K., Yokoyama, T., Matsuura, Y., Piatyszek, M. A., & Shay, J. W. (1995) · Nature Medicine · doi:10.1038/nm0395-249 · Cited by 611
Crystal structure of four-stranded Oxytricha telomeric DNA
Kang, C., Zhang, X., Ratliff, R., Moyzis, R., & Rich, A. (1992) · Nature · doi:10.1038/356126a0 · Cited by 555
The High-Resolution Crystal Structure of a Parallel-Stranded Guanine Tetraplex
Laughlan, G., Murchie, A. I. H., Norman, D. G., Moore, M. H., Moody, P. C. E., Lilley, D. M. J., & Luisi, B. (1994) · Science · doi:10.1126/science.8036494 · Cited by 482
Telomerase Activity in Small-Cell and Non-Small-Cell Lung Cancers
Hiyama, K., Hiyama, E., Ishioka, S., Yamakido, M., Inai, K., Gazdar, A. F., Piatyszek, M. A., & Shay, J. W. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.12.895 · Cited by 440
Research works printed but not linked: 10
- Telomeres, 1995, Cold Spring Harbor Press: New York
- Harley C. B., 1994, Cancer. Cold Spring Harbor Symp. Quant. Biol.
- Broccoli D., 1994, Proc. Natl. Acad. Sci. U.S.A., 92, 9086
- Rhyu M. S., 1995, J. Natl. Cancer Inst., 87, 894
- Salazar M., 1996, Biochemistry, 35, 16115
- Fox K. R., 1995, Proc. Natl. Acad. Sci. U.S.A., 92, 7891
- Haq I., 1996, J. Am. Chem. Soc., 118, 10701
- Tanious F. A., 1992, Biochemistry, 31, 11640
- Wang Y., 1992, Biochemistry, 31, 8119
- Chen Q., 1996, Proc. Natl. Acad. Sci. U.S.A., 93, 2639
Cited by
Items 201–300 of 828
Martins, C., Gunaratnam, M., Stuart, J. W., Makwana, V., Greciano, O., Reszka, A. P., Kèlland, L. R., & Neidle, S. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.01.056 · Cited by 74
Self-citationAscididemin and meridine stabilise G-quadruplexes and inhibit telomerase in vitro
Guittat, L., Cian, A. D., Rosu, F., Gabelica, V., Pauw, E. D., Delfourne, E., & Mergny, J. (2005) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2005.04.023 · Cited by 71
“The number of G4 ligands has grown rapidly over a few years: a range of molecules has been shown to inhibit telomerase through binding to its substrate [14,26,27,36,44-59].”
BackgroundTelomeres, telomerase, and cancer: life on the edge of genomic stability
Oulton, R., & Harrington, L. A. (2000) · Current Opinion in Oncology · doi:10.1097/00001622-200001000-00013 · Cited by 78
The Interaction of Telomeric DNA and C-myc22 G-Quadruplex with 11 Natural Alkaloids
Ji, X., Sun, H., Zhou, H., Xiang, J., Tang, Y., & Zhao, C. (2012) · Nucleic Acid Therapeutics · doi:10.1089/nat.2012.0342 · Cited by 70
“…between small molecules and G4 DNA in 1997 (Wang et al., 2010), many leading compounds that target G4 have been found, including anthraquinones (Sun et al., 1997; Perry et al., 1998a, 1998b), cationic porphyrins (Anantha et al., 1998; Han et al., 2001), perylene (Rossetti et al., 2002),…”
Binding and Beyond: What Else Can G‐Quadruplex Ligands Do?
O’Hagan, M., Morales, J. C., & Galán, M. C. (2019) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201900692 · Cited by 72
Telomeres and Telomerase: From Discovery to Clinical Trials
Corey, D. R. (2009) · Chemistry & Biology · doi:10.1016/j.chembiol.2009.12.001 · Cited by 73
“Many different quadruplex-stabilizing agents have been identified (Sun et al., 1997) and several have been shown to have antiproliferative effects (Read et al., 2001; Riou, 2003).”
Chilka, P., Desai, N. N., & Datta, B. (2019) · Molecules · doi:10.3390/molecules24040752 · Cited by 69
“G4-targeting ligands have been demonstrated to trigger cellular responses correlated with the perceived function of corresponding quadruplexes [9,10].”
BackgroundTelomerase: a therapeutic target for the third millennium?
Lavelle, F., Riou, J., Laoui, A., & Mailliet, P. (2000) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(00)00057-3 · Cited by 74
Arora, A., & Maiti, S. (2009) · The Journal of Physical Chemistry B · doi:10.1021/jp809486g · Cited by 68
Rational Design of Substituted Diarylureas: A Scaffold for Binding to G-Quadruplex Motifs
Drewe, W. C., Nanjunda, R. K., Gunaratnam, M., Beltran, M., Parkinson, G. N., Reszka, A. P., Wilson, W. D., & Neidle, S. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm801245v · Cited by 73
Self-citationMurakami, J., Nagai, N., Shigemasa, K., & Ohama, K. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00037-4 · Cited by 68
G‐Quadruplex Formation Interferes with P1 Helix Formation in the RNA Component of Telomerase hTERC
Gros, J., Guédin, A., Mergny, J., & Lacroix, L. (2008) · ChemBioChem · doi:10.1002/cbic.200800300 · Cited by 77
Garavís, M., Méndez-Lago, M., Gabelica, V., Whitehead, S. L., González, C., & Villasanté, A. (2015) · Scientific Reports · doi:10.1038/srep13307 · Cited by 66
Bates, P. J., Mergny, J., & Yang, D. (2007) · EMBO Reports · doi:10.1038/sj.embor.7401073 · Cited by 66
“The intramolecular telomeric G-quadruplex has been considered to be an attractive target for anticancer drug design ever since quadruplex ligands were found to inhibit telomerase, an enzyme that is activated in most cancer cells but not in most non-cancerous cells (Sun et al, 1997).”
BackgroundStructure-activity relationships among guanine-quadruplex telomerase inhibitors
Neidle, S., Harrison, R. J., Reszka, A. P., & Read, M. A. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00065-0 · Cited by 70
Self-citationChen, Z., Koeneman, K. S., & Corey, D. R. (2003) · PubMed · Cited by 72
Aminoglycoside Binding toOxytricha novaTelomeric DNA
Ranjan, N., Andreasen, K. F., Kumar, S., Hyde-Volpe, D., & Arya, D. P. (2010) · Biochemistry · doi:10.1021/bi101517e · Cited by 64
“common feature of being planar compounds such as anthraquinones (15), porphyrinderivatives (16-18), quinacridines (19), anthra-”
TELOMERASE IN UROLOGICAL MALIGNANCY
Orlando, C., Gelmini, S., Selli, C., & Pazzagli, M. (2001) · The Journal of Urology · doi:10.1016/s0022-5347(05)66040-5 · Cited by 68
Telomeres and telomerase as targets for cancer therapy
Zimmermann, S., & Martens, U. M. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-6481-8 · Cited by 71
Zhang, Q., Liu, Y., Kong, D., & Guo, D. (2015) · Chemistry - A European Journal · doi:10.1002/chem.201501847 · Cited by 63
Islam, M. K., Jackson, P. J., Rahman, K. M., & Thurston, D. E. (2016) · Future Medicinal Chemistry · doi:10.4155/fmc-2015-0017 · Cited by 64
Molecular Modeling and Simulation of G-Quadruplexes and Quadruplex-Ligand Complexes
Haider, S. M., & Neidle, S. (2009) · Methods in molecular biology · doi:10.1007/978-1-59745-363-9_2 · Cited by 62
“Small-molecule ligands can promote the formation of quadruplex structures from telomeric DNA, which can then inhibit the telomerase enzyme and destabilize telomere end-capping in cancer cells (10).”
BackgroundSelf-citationEnergetics of the Human Tel-22 Quadruplex−Telomestatin Interaction: A Molecular Dynamics Study
Agrawal, S., Ojha, R. P., & Maiti, S. (2008) · The Journal of Physical Chemistry B · doi:10.1021/jp7102676 · Cited by 62
Zhou, W.-J., Deng, R., Zhang, X.-Y., Feng, G.-K., Gu, L.-Q., & Zhu, X.-F. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0244 · Cited by 61
“Several classes of small molecules have been identified to interact with and stabilize G-quadruplexes, including tricyclic anthraquinones (20), fluorenones (21), substituted acridines (22, 23), cationic porphyrins (24, 25), telomestatin (SOT-095; ref.”
BackgroundWang, Y., Cheng, F. X., Yuan, X. L., Tang, W. J., Shi, J., Liao, C., & Liu, X. H. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.02.009 · Cited by 62
Telomerase: Key regulator of inflammation and cancer
Wu, L., Fidan, K., Um, J., & Ahn, K. S. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104726 · Cited by 66
Kim, M.-Y., Duan, W., Gleason-Guzman, M. C., & Hurley, L. H. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm0203377 · Cited by 62
Self-citationDual recognition of the human telomeric G-quadruplex by a neomycin–anthraquinone conjugate
Ranjan, N., Davis, E., Xue, L., & Arya, D. P. (2013) · Chemical Communications · doi:10.1039/c3cc42721h · Cited by 61
Mechanistic Insights into the Ligand-Induced Unfolding of an RNA G-Quadruplex
Haldar, S., Zhang, Y., Xia, Y., Islam, B., Liu, S., Gervasio, F. L., Mulholland, A. J., Waller, Z. A. E., Wei, D., & Haider, S. M. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.1c11248 · Cited by 61
Therapeutic strategies for targeting telomerase in cancer
Chen, X., Tang, W., Shi, J., Liu, M. M., & Liu, X. (2019) · Medicinal Research Reviews · doi:10.1002/med.21626 · Cited by 65
Quadruplex Ligands in Cancer Therapy
Sánchez-Martín, V., Soriano, M., & Garcia-Salcedo, J. A. (2021) · Cancers · doi:10.3390/cancers13133156 · Cited by 60
“Cancers 2021, 13, 3156 7 of 25 Indoloquinolines * c-KIT [69]; c-MYC [70]; k-RAS [69];Tel [69]; VEGF [71] Inhibition of oncogene transcription and telomere dysfunction Isoalloxazines c-KIT [72] Inhibition of oncogene transcription IZCZ-3 * c-MYC [73] Inhibition of oncogene transcription IZNP-1 Tel [74] Telomere dysfunc…”
BackgroundInfluentialShikonin derivatives: synthesis and inhibition of human telomerase
Lu, Q., Liu, W., Ding, J., Cai, J., & Duan, W. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00158-0 · Cited by 60
Fluorescent functional nucleic acid: Principles, properties and applications in bioanalyzing
Wang, X. X., Zhu, L. J., Li, S. T., Zhang, Y. Z., Liu, S. Y., Huang, K. L., & Xu, W. T. (2021) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2021.116292 · Cited by 62
Zagotto, G., Sissi, C., Lucatello, L., Pivetta, C., Cadamuro, S. A., Fox, K. R., Neidle, S., & Palumbo, M. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800160v · Cited by 60
Self-citationTargeting human telomeric G-quadruplex DNA with oxazole-containing macrocyclic compounds
Pilch, D. S., Barbieri, C. M., Rzuczek, S. G., LaVoie, E. J., & Rice, J. E. (2008) · Biochimie · doi:10.1016/j.biochi.2008.03.011 · Cited by 65
“In addition to telomestatin, a diverse array of G-quadruplex-stabilizing compounds has been identified to date, including anthraquinones [62,63], acridines [64–68], cationic porphyrins [69–78], bistriazoles [79], perylenes [80–82], ethidium derivatives [83,84], fluorenones [85], pentacyclic acridinium salts [86–88], a…”
BackgroundHuman Telomeric G-Quadruplex Structures and G-Quadruplex-Interactive Compounds
Lin, C., & Yang, D. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-6892-3_17 · Cited by 66
“Targeting of DNA G-quadruplex secondary structures represents a new approach for cancer therapeutics [1, 7, 38–40], with the first report of targeting G-quadruplexes for inhibiting telomerase activity in 1997 [41].”
BackgroundG4-Interacting DNA Helicases and Polymerases: Potential Therapeutic Targets
Estep, K. N., Butler, T. J., Ding, J., & Brosh, R. M. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867324666171116123345 · Cited by 58
Analytical potential of the quadruplex DNA-based FRET probes
Juskowiak, B. (2006) · Analytica Chimica Acta · doi:10.1016/j.aca.2005.12.063 · Cited by 58
DNA folds threaten genetic stability and can be leveraged for chemotherapy
Zell, J., Sperti, F. R., Britton, S., & Monchaud, D. (2021) · RSC Chemical Biology · doi:10.1039/d0cb00151a · Cited by 62
G4-PROTAC: targeted degradation of a G-quadruplex binding protein
Patil, K. M., Chin, D., Seah, H. L., Shi, Q., Lim, K. W., & Phan, A. T. (2021) · Chemical Communications · doi:10.1039/d1cc05025g · Cited by 60
Porphyrin–aminoquinoline conjugates as telomerase inhibitors
Maraval, A., Franco, S., Vialas, C., Pratviel, G., Blasco, M. A., & Meunier, B. (2003) · Organic & Biomolecular Chemistry · doi:10.1039/b211634k · Cited by 66
Savva, L., & Georgiades, S. N. (2021) · Molecules · doi:10.3390/molecules26040841 · Cited by 59
“A resulting inhibition of telomerase activity upon addition of such ligands has been reported [68], while several ligands are able to displace members of the telomere protection complex shelterin, resulting in telomere damage and cell death [59,69].”
BackgroundGarcía‐Beccaria, M., Martínez, P., Méndez‐Pertuz, M., Martínez, S., Blanco‐Aparicio, C., Cañamero, M., Mulero, F., Ambrogio, C., Flores, J. M., Megias, D., et al. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201404497 · Cited by 55
“Telomeric repeats can also form DNA higher order structures known as G-quartets, and molecules that stabilize G-quartets have also been proposed to inhibit telomerase-mediated telomere elongation in cancer (Sun et al , 1997; Shin-ya et al , 2001; Huang et al , 2008).”
Effects of Site-Specific Guanine C8-Modifications on an Intramolecular DNA G-Quadruplex
Lech, C. J., Lim, J. K. C., Lim, J. M. W., Amrane, S., Heddi, B., & Phan, A. T. (2011) · Biophysical Journal · doi:10.1016/j.bpj.2011.08.049 · Cited by 57
“org/biophysj/supplemental/S0006-3495(11)01054-X.”
Petraccone, L., Garbett, N. C., Chaires, J. B., & Trent, J. O. (2010) · Biopolymers · doi:10.1002/bip.21392 · Cited by 60
Self-citationFletcher, T. M., Cathers, B. E., Ravikumar, K. S., Mamiya, B. M., & Kerwin, S. M. (2001) · Bioorganic Chemistry · doi:10.1006/bioo.2000.1194 · Cited by 65
Self-citationG-Quadruplex binding enantiomers show chiral selective interactions with human telomere
Wang, J., Chen, Y., Ren, J., Zhao, C., & Qu, X. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1354 · Cited by 57
Synthesis and G-quadruplex binding studies of new 4-N-methylpyridinium porphyrins
Gonçalves, D. P. N., Ladame, S., Balasubramanian, S., & Sanders, J. K. M. (2006) · Organic & Biomolecular Chemistry · doi:10.1039/b608494j · Cited by 56
Seven essential questions on G-quadruplexes
König, S. L. B., Evans, A. C., & Huppert, J. L. (2010) · BioMolecular Concepts · doi:10.1515/bmc.2010.011 · Cited by 71
The DNA secondary structures at telomeres and genome instability
Tan, J. J., & Lan, L. (2020) · Cell & Bioscience · doi:10.1186/s13578-020-00409-z · Cited by 59
The human telomere and its relationship to human disease, therapy, and tissue engineering
Moon, I. (2007) · Frontiers in Bioscience · doi:10.2741/2412 · Cited by 54
“The combined efforts of the Hurley and Neidle labs provided the first study of G-quadruplex-binding ligands, 2,6-diamidoanthraquinones, as telomerase inhibitors (231).”
BackgroundInteractions of small molecules with DNA junctions
McQuaid, K. T., Pipier, A., Cardin, C. J., & Monchaud, D. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac1043 · Cited by 57
“Hurley and co-workers on a small molecule able to interact with a G4 (in the aim of indirectly inhibiting telomerase via the sequestration of its telomeric substrate under a form that is not recognized by the enzyme) (205), hundreds of G4 ligands have been synthesized and studied (75,206).”
BackgroundPunnoose, J. A., Ma, Y., Li, Y., Sakuma, M., Mandal, S., Nagasawa, K., & Mao, H. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b00607 · Cited by 56
NMR Studies of G-Quadruplex Structures and G-Quadruplex-Interactive Compounds
Lin, C., Dickerhoff, J., & Yang, D. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9666-7_9 · Cited by 54
Paudel, B. P., Moye, A. L., Assi, H. A., El-Khoury, R., Cohen, S. B., Holien, J. K., Birrento, M. L., Samosorn, S., Intharapichai, K., Tomlinson, C. G., et al. (2020) · eLife · doi:10.7554/elife.56428 · Cited by 54
Platinum squares with high selectivity and affinity for human telomeric G-quadruplexes
Zheng, X., Chen, H., Tong, M., Ji, L., & Mao, Z. (2012) · Chemical Communications · doi:10.1039/c2cc32942e · Cited by 54
Cogoi, S., Shchekotikhin, A. E., Membrino, A., Sinkevich, Y. B., & Xodo, L. E. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm3019063 · Cited by 52
Interaction of Polycationic Ni(II)-Salophen Complexes with G-Quadruplex DNA
Lecarme, L., Prado, É., Rache, A. D., Nicolau-Travers, M.-L., Bonnet, R., der Heyden, A. V., Philouze, C., Gómez, D., Mergny, J., Jamet, H., et al. (2014) · Inorganic Chemistry · doi:10.1021/ic502063r · Cited by 54
Anthracene-terpyridine metal complexes as new G-quadruplex DNA binders
Gama, S., Rodrigues, I., Mendes, F., Santos, I. C., Gabano, E., Klejevskaja, B., González‐García, J., Ravera, M., Vilar, R., & Paulo, A. (2016) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2016.04.002 · Cited by 52
Pelliccia, S., Amato, J., Capasso, D., Gaetano, S. D., Massarotti, A., Piccolo, M., Irace, C., Tron, G. C., Pagano, B., Randazzo, A., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00262 · Cited by 52
Telomeres as targets for anticancer therapies
Folini, M., Venturini, L., Cimino-Reale, G., & Zaffaroni, N. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.556621 · Cited by 54
“The concept that telomeric G4 can represent a therapeutic target was established by the observation that a group of disubstituted amidoanthraquinones containing a planar aromatic chromophore could inhibit telomerase activity [61].”
BackgroundA “Double-Edged” Scaffold: Antitumor Power within the Antibacterial Quinolone
Bisacchi, G. S., & Hale, M. R. (2016) · Current Medicinal Chemistry · doi:10.2174/0929867323666151223095839 · Cited by 58
“} During that time, Hurley was simultaneously interested in G-quadruplex biology and the implications of modulating quadruplex structure by small molecules [250].”
BackgroundHuang, H., Chen, I., Huang, K.-F., Lu, W.-C., Shieh, F.-Y., Huang, Y.-Y., Huang, F.-C., & Lin, J. (2007) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.55.284 · Cited by 51
DNA and the chromosome – varied targets for chemotherapy
Nelson, S. M., Ferguson, L. R., & Denny, W. A. (2004) · Cell & Chromosome · doi:10.1186/1475-9268-3-2 · Cited by 72
“Nuclear magnetic resonance studies have confirmed that the 2,6-diamidoanthraquinone BSU1051 [19] interacts with and stabilizes the G-quartet, and inhibits telomerase activity[125].”
BackgroundZheng, X., Zhong, Y.-F., Tan, C., Ji, L., & Mao, Z. (2012) · Dalton Transactions · doi:10.1039/c2dt31303k · Cited by 50
Huang, F., Chang, C., Lou, P., Kuo, I.-C., Chien, C., Chen, C., Shieh, F.-Y., Chang, T., & Lin, J. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-0260 · Cited by 53
“In addition to BMVC, there were many telomerase inhibitors that have been identified based on G-quadruplex stabilizing activity (20-24).”
BackgroundInteractions of daidzin with intramolecular G‐quadruplex
Li, W., Zhang, M., Zhang, J., Li, H., Zhang, X.-C., Sun, Q., & Qiu, C.-M. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.08.007 · Cited by 50
“anthraquinones [11], porphyrins [12], acridines[13], perylenes [14] and triazines [15,16], to natural compounds such as telomestatin [17], ascididemin [18], and alkaloid berberine [19].”
BackgroundNucleic acids targeted to drugs: SELEX against a quadruplex ligand
de la Faverie, A. R., Hamon, F., Primo, C. D., Largy, E., Dausse, E., Delaurière, L., Guetta, C., Toulmé, J., Teulade‐Fichou, M., & Mergny, J. (2011) · Biochimie · doi:10.1016/j.biochi.2011.05.022 · Cited by 53
Sun, J., An, Y., Zhang, L., Chen, H., Han, Y., Wang, Y., Mao, Z., & Ji, L. (2010) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2010.10.005 · Cited by 49
Disordering of Human Telomeric G-Quadruplex with Novel Antiproliferative Anthrathiophenedione
Kaluzhny, D. N., Ilyinsky, N. S., Shchekotikhin, A. E., Sinkevich, Y. B., Tsvetkov, P. O., Цветков, В. Б., Veselovsky, A. V., Livshits, M. A., Borisova, O. F., Shtil, A. A., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027151 · Cited by 49
“to inhibit human telomerase via stabilization of telomeric Gquadruplex structures [9,10].”
BackgroundA Carbazole Derivative Synthesis for Stabilizing the Quadruplex Structure
Chang, C., Wu, J., & Chang, T. (2003) · Journal of the Chinese Chemical Society · doi:10.1002/jccs.200300026 · Cited by 49
Agarwal, T., Roy, S., Chakraborty, T. K., & Maiti, S. (2010) · Biochemistry · doi:10.1021/bi1005927 · Cited by 49
Role of the central cations in the mechanical unfolding of DNA and RNA G-quadruplexes
Bergues-Pupo, A. E., Arias‐Gonzalez, J. R., Morón, M. C., Fiasconaro, A., & Falo, F. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv690 · Cited by 49
Huang, H., Huang, K.-F., Li, C.-L., Huang, Y.-Y., Chiang, Y.-H., Huang, F.-C., & Lin, J. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.05.072 · Cited by 48
Photoresponsive Control of G-Quadruplex DNA Systems
Ramos‐Soriano, J., & Galán, M. C. (2021) · JACS Au · doi:10.1021/jacsau.1c00283 · Cited by 50
Berner, A., Das, R. N., Bhuma, N., Golebiewska, J., Abrahamsson, A., Andréasson, M., Chaudhari, N., Doimo, M., Bose, P. P., Chand, K., et al. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.3c14408 · Cited by 50
Ruthenium( ii ) polypyridyl complexes as dual inhibitors of telomerase and topoisomerase
Liao, G., Chen, X., Wu, J., Qian, C., Wang, Y., Ji, L., & Chao, H. (2015) · Dalton Transactions · doi:10.1039/c4dt03585b · Cited by 49
Structure-based design of selective high-affinity telomeric quadruplex-binding ligands
Lombardo, C. M., Martínez, I. S., Haider, S. M., Gabelica, V., Pauw, E. D., Moses, J. E., & Neidle, S. (2010) · Chemical Communications · doi:10.1039/c0cc02917c · Cited by 47
Self-citationRoy, S., Ali, A., Kamra, M., Muniyappa, K., & Bhattacharya, S. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112202 · Cited by 47
G-Quadruplex DNA binding by a series of carbocyanine dyes
Kerwin, S. M., Sun, D., Kern, J. T., Rangan, A., & Thomas, P. W. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00490-5 · Cited by 47
Self-citationTelomerase and cancer: time to move from a promising target to a clinical reality
Keith, W. N., Evans, T. R. J., & Glasspool, R. M. (2001) · The Journal of Pathology · doi:10.1002/path.1001 · Cited by 55
All-Atomic Simulations on Human Telomeric G-Quadruplex DNA Binding with Thioflavin T
Luo, D., & Mu, Y. (2015) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.5b01107 · Cited by 48
Protonation of Cytosine: Cytosinium vs Hemicytosinium Duplexes
Perumalla, S. R., Pedireddi, V. R., & Sun, C. C. (2013) · Crystal Growth & Design · doi:10.1021/cg3014915 · Cited by 46
Yaku, H., Murashima, T., Tateishi‐Karimata, H., Nakano, S., Miyoshi, D., & Sugimoto, N. (2013) · Methods · doi:10.1016/j.ymeth.2013.03.028 · Cited by 48
Loop flexibility in human telomeric quadruplex small-molecule complexes
Collie, G. W., Campbell, N. H., & Neidle, S. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv427 · Cited by 45
“The concept that quadruplexbinding small molecules can stabilise telomeric quadruplexes (9), has been widely used to discover small molecules with potential anti-cancer activity via inhibition of the action of the telomerase enzyme complex (10–14).”
BackgroundSelf-citationMetal-Based G-Quadruplex Binders for Cancer Theranostics
Palma, E., Carvalho, J., Cruz, C., & Paulo, A. (2021) · Pharmaceuticals · doi:10.3390/ph14070605 · Cited by 48
“This concept was first validated through the demonstration that the compound 2,6-diamidodianthraquinone could inhibit the activity of telomerase by interacting with and stabilizing G4 structures [22].”
BackgroundReplicative senescence and senescence-like state induced in cancer-derived cells
Hwang, E. S. (2002) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(02)00102-1 · Cited by 47
State-of-the-Art Methodologies for the Discovery and Characterization of DNA G-Quadruplex Binders
Pagano, B., Cosconati, S., Gabelica, V., Petraccone, L., Tito, S. D., Marinelli, L., Pietra, V. L., Leva, F. S. D., Lauri, I., Trotta, R., et al. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212799958332 · Cited by 46
“After the discovery that a disubstituted anthraquinone derivative was first able to inhibit telomerase activity via quadruplex induction and stabilization [24], many quadruplex-binding ligands have been proposed [5, 13, 25].”
BackgroundLigands stimulating antitumour immunity as the next G-quadruplex challenge
Miglietta, G., Marinello, J., Russo, M., & Capranico, G. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01649-y · Cited by 44
“Historically, G4 binders were designed to target telomeres with the aim to inhibit telomerase activity and consequently proliferation rate of immortalized cancer cells [44, 45].”
BackgroundLogic gates based on G-quadruplexes: principles and sensor applications
Guo, Y., Yao, W., Xie, Y., Zhou, X., Hu, J., & Pei, R. (2015) · Microchimica Acta · doi:10.1007/s00604-015-1633-2 · Cited by 46
“[56] first characterized the G4 structure by using fluorescent dye.”
Patel, S. D., Isalan, M., Gavory, G., Ladame, S., Choo, Y., & Balasubramanian, S. (2004) · Biochemistry · doi:10.1021/bi048892t · Cited by 45
“The interaction was therefore studied by nondenaturing gel mobility shift analysis (5, 6, 10, 32) and by DMS protection assays (20).”
BackgroundMethodTelomerase: biology and phase I trials
Kèlland, L. R. (2001) · The Lancet Oncology · doi:10.1016/s1470-2045(00)00226-6 · Cited by 47
The application of click chemistry for targeting quadruplex nucleic acids
Saha, P., Panda, D., & Dash, J. (2018) · Chemical Communications · doi:10.1039/c8cc07107a · Cited by 44
Synthesis of distamycin A polyamides targeting G-quadruplex DNA
Moore, M. M., Cuenca, F., Searcey, M., & Neidle, S. (2006) · Organic & Biomolecular Chemistry · doi:10.1039/b607707b · Cited by 43
Self-citationZhang, H., Wang, X., Wang, P., Ai, X., & Zhang, J. (2008) · Photochemical & Photobiological Sciences · doi:10.1039/b809322a · Cited by 43
Benzoindoloquinolines interact with DNA tetraplexes and inhibit telomerase
Alberti, P., Schmitt, P., Nguyen, C.-H., Rivalle, C., Hoarau, M., Grierson, D. S., & Mergny, J. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00080-x · Cited by 43
Synthesis of Bis‐indole Carboxamides as G‐Quadruplex Stabilizing and Inducing Ligands
Dash, J., Das, R. N., Hegde, N. S., Pantoş, G. D., Shirude, P. S., & Balasubramanian, S. (2011) · Chemistry - A European Journal · doi:10.1002/chem.201102556 · Cited by 43
Street, S. T. G., Chin, D. N., Hollingworth, G. J., Berry, M., Morales, J. C., & Galán, M. C. (2017) · Chemistry - A European Journal · doi:10.1002/chem.201700140 · Cited by 42
Energetics of Quadruplex-Drug Recognition in Anticancer Therapy
Pagano, B., & Giancola, C. (2007) · Current Cancer Drug Targets · doi:10.2174/156800907781662257 · Cited by 43
A homogeneous time-resolved fluorescence detection of telomerase activity
Gabourdes, M., Bourgine, V., Mathis, G., Bazin, H., & Alpha‐Bazin, B. (2004) · Analytical Biochemistry · doi:10.1016/j.ab.2004.06.006 · Cited by 44
“[32] for this anthraquinone derivative using a standard primer extension assay.”
BackgroundMethod
Metadata
- Authors
- Sun, D., Thompson, B., Cathers, B. E., Salazar, M., Kerwin, S. M., Trent, J. O., Jenkins, T. C., Neidle, S., & Hurley, L. H.
- Affiliations
- The University of Texas at Austin (US)
- ORCID
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 1997-07-01
- Volume
- 40
- Issue
- 14
- Pages
- 2113-2116
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2025811126
- Semantic Scholar
- 67b8d8f99c37d9233c470812b601e6637423725f
- Cited by
- 794
- References
- 21
- Citations by year
- 2026: 12 · 2025: 10 · 2024: 29 · 2023: 19 · 2022: 46 · 2021: 46 · 2020: 35 · 2019: 27 · 2018: 27 · 2017: 20 · 2016: 36 · 2015: 42 · 2014: 38 · 2013: 33 · 2012: 39
- FWCI
- 4.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Medicinal Chemistry (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- National Institutes of Health (7u19ca067760-05)
- National Cancer Institute (CA-67760, CA 49751)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA and Nucleic Acid Chemistry
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Metal complexes synthesis and properties
- Keywords
- G-quadruplex, human telomerase reverse transcriptase, telomere replication, anticancer agents
- MeSH terms
- Anthraquinones, Base Sequence, DNA, Enzyme Inhibitors, Humans, Nucleic Acid Conformation, Nucleic Acid Denaturation, Oligodeoxyribonucleotides, Molecular Structure, Telomerase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.